Next Article in Journal
Homeobox Genes and Hepatocellular Carcinoma
Previous Article in Journal
Fibroblasts as Modulators of Local and Systemic Cancer Metabolism
 
 
Review
Peer-Review Record

Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer

Cancers 2019, 11(5), 620; https://doi.org/10.3390/cancers11050620
by Connor O’Leary 1,2,*, Wen Xu 1, Nick Pavlakis 3, Derek Richard 2 and Ken O’Byrne 1,2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2019, 11(5), 620; https://doi.org/10.3390/cancers11050620
Submission received: 16 April 2019 / Revised: 30 April 2019 / Accepted: 30 April 2019 / Published: 3 May 2019

Round 1

Reviewer 1 Report

In my opinion this paper is well written and describes the full landscape of RET+ NSCLC.

I think that the different chapters about MK TKI, selective TKI and immunotherapie and chemotherapy are of good length and complete.

One item should be given in more detail: PFS and OS confident intervals are missing

Author Response

I have made the modifications you have suggested and added confidence intervals to the PFS and OS values. 

Many thanks for comments and appreciate you taking the time to review this article.

Reviewer 2 Report

This comprehensive review covers the ongoing clinical trial for patients with RET rearrangement. These review is interesting and is worth for publication.

Author Response

Many thanks for comments and appreciate you taking the time to review this article.

Back to TopTop